- Home
- GHRS vs ZIMV Comparison
GHRS vs ZIMV Comparison
Compare GHRS & ZIMV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- ZIMV
- Stock Information
- Founded
- GHRS 2018
- ZIMV 2021
- Country
- GHRS Ireland
- ZIMV United States
- Employees
- GHRS N/A
- ZIMV N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GHRS Health Care
- ZIMV Health Care
- Exchange
- GHRS Nasdaq
- ZIMV Nasdaq
- Market Cap
- GHRS 462.0M
- ZIMV 379.2M
- IPO Year
- GHRS 2021
- ZIMV N/A
- Fundamental
- Price
- GHRS $8.99
- ZIMV $14.33
- Analyst Decision
- GHRS Strong Buy
- ZIMV Buy
- Analyst Count
- GHRS 3
- ZIMV 2
- Target Price
- GHRS $35.67
- ZIMV $19.50
- AVG Volume (30 Days)
- GHRS 89.4K
- ZIMV 112.4K
- Earning Date
- GHRS 02-27-2025
- ZIMV 02-26-2025
- Dividend Yield
- GHRS N/A
- ZIMV N/A
- EPS Growth
- GHRS N/A
- ZIMV N/A
- EPS
- GHRS N/A
- ZIMV N/A
- Revenue
- GHRS N/A
- ZIMV $451,294,000.00
- Revenue This Year
- GHRS N/A
- ZIMV $0.74
- Revenue Next Year
- GHRS N/A
- ZIMV $1.23
- P/E Ratio
- GHRS N/A
- ZIMV N/A
- Revenue Growth
- GHRS N/A
- ZIMV 267.15
- 52 Week Low
- GHRS $5.92
- ZIMV $13.01
- 52 Week High
- GHRS $14.99
- ZIMV $22.40
- Technical
- Relative Strength Index (RSI)
- GHRS 58.18
- ZIMV 58.68
- Support Level
- GHRS $8.02
- ZIMV $13.65
- Resistance Level
- GHRS $10.23
- ZIMV $13.71
- Average True Range (ATR)
- GHRS 0.90
- ZIMV 0.38
- MACD
- GHRS 0.11
- ZIMV 0.07
- Stochastic Oscillator
- GHRS 62.20
- ZIMV 83.24
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.